Direct conversion of cellulose to L-lactic acid by a novel thermophilic Caldicellulosiruptor strain

By al | Albrecht Läufer
•
02 May, 2022
•

After major breakthroughs in the evolutionary adaptation of the proprietary Caldicellulosiruptor strain, BluCon Biotech now published its developmental work towards second-generation L-lactic acid production in the peer-reviewed journal Biotechnology for Biofuels and Bioproducts.

MAY 02, 2022

In this article, the ingenious steps of the evolutionary adaptation process are described that led to an increase in L-lactic acid production from 6 to 70 g/l from cellulose without the addition of external enzymes. Caldicellulosiruptor is able to simultaneously saccharify and ferment substrates and is therefore a promising candidate for consolidated bioprocessing. The recent achieved milestones accelerate BluCon Biotech’s ambitious goals and pave the way to accomplish its mission to develop a commercially viable and sustainable industrial process to produce L-lactic acid from agricultural and industrial lignocellulosic residues streams.

20220502-Direct conversion of cellulose to L-lactic acid by a novel thermophilic Caldicellulosiruptor strain

Share

Mail

BluCon Biotech welcomes strategic investment by major chemical group LG Chem

By unn | UNITED NEWS NETWORK GmbH 2002–2023 • 09 Mar, 2023

BluCon Biotech, a German biotech company, and LG Chem, a leading chemical company, have entered into an investment agreement to scale up and commercialize BluCon Biotech’s proprietary technology to supplement LG Chem´s bio-economy portfolio BluCon Biotech’s technology has the potential to be a disruptive game changer in the world's plastics market by using direct fermentation of lignocellulosic feedstock to lactic acid to achieve bioplastic PLA that is price-competitive with fossil-based plastics, contributing to a sustainable circular bio-economy BluCon Biotech and LG Chem agreed to work together on a novel process for converting non-food lignocellulosic feedstocks into high purity lactic acid, a precursor for bio-based and biodegradable plastics.

BluCon Biotech begrüßt strategische Investition des Chemiekonzerns LG Chem

By unn | UNITED NEWS NETWORK GmbH 2002–2023 • 09 Mar, 2023

BluCon Biotech GmbH, ein deutsches Biotech-Unternehmen, und LG Chem Ltd., ein führender koreanisches Chemiekonzern, haben eine Investitionsvereinbarung geschlossen, um die patentrechtlich geschützte Technologie von BluCon Biotech zu erweitern und zu kommerzialisieren und um das Bioökonomie-Portfolio von LG Chem zu ergänzen.

NRW-Wirtschaftsminister Prof. Dr. Andreas Pinkwart besucht BluCon Biotech auf dem BioCampus Cologne

By BluCon Biotech GmbH • 02 Aug, 2022

Am 11.05. machte Prof. Pinkwart mal wieder dem BioCampus seine Aufwartung und nutzte die Gelegenheit, sich von der Innovationskraft eines ansässigen Startups zu überzeugen.

BluCon Biotech erhält Förderung im Rahmen der Maßnahmen aus der Dialogplattform Industrielle Bioökonomie

By mf | blucon biotech news • 01 Dec, 2021

BluCon Biotech erhält Förderung im Rahmen der Maßnahmen aus der Dialogplattform Industrielle Bioökonomie Das BIO Deutschland-Mitglied BluCon Biotech GmbH hat am 24. November in Köln einen Zuwendungsbescheid über 931.111 Euro vom Bundesministerium für Wirtschaft und Energie (BMWi) erhalten.